Parkinson's disease (PD) is a progressive neurodegenerative disorder primarily affecting the motor system. Despite its prevalence, PD's etiology remains complex and multifaceted. This article aims to provide a comprehensive overview of the disease, discussing its pathophysiology, clinical presentation, diagnosis, and current treatment options.
PD is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta, leading to striatal dopamine deficiency. The accumulation of alpha-synuclein in Lewy bodies is a key pathological feature. The exact cause of neuronal death is unclear, but genetic and environmental factors have been implicated.
PD typically presents with motor symptoms such as bradykinesia, rigidity, and resting tremor. Non-motor symptoms can include autonomic dysfunction, sleep disturbances, and cognitive impairment. The disease's progression is variable, with some patients remaining functionally independent for many years, while others experience rapid decline.
Diagnosis is primarily clinical, based on the presence of characteristic motor symptoms and response to dopaminergic therapy. Neuroimaging can support the diagnosis but is not routinely used due to its limited sensitivity and specificity.
Treatment focuses on managing symptoms and improving quality of life. Pharmacological therapy, including levodopa and dopamine agonists, forms the cornerstone of management. Non-pharmacological interventions, such as physiotherapy and occupational therapy, also play a crucial role. Deep brain stimulation may be considered in patients with refractory symptoms.
In conclusion, PD is a complex neurodegenerative disorder with diverse clinical manifestations and a variable course. A deep understanding of its pathophysiology, clinical presentation, diagnosis, and treatment options is essential for healthcare professionals to provide optimal patient care.
1.
New Nanoparticles Can Destroy Undruggable Cancer Proteins
2.
Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer
3.
NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.
4.
Belzutifan Plus Pembro Approved for Adjuvant RCC
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide
2.
Obesity as a major risk factor for cancer
3.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
4.
Advanced Pathways in Oncology for Better Care
5.
Essential Updates in Hematology in Daily Practice
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Understanding Anemia and Its Common Causes
4.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
5.
Early Cancer Detection Saves Lives
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation